<DOC>
	<DOCNO>NCT02105103</DOCNO>
	<brief_summary>Accu-Chek® Insight Insulin Pump EU Study Multicenter Study evaluate Accu-Chek® Insight Insulin Pump routine practice . This open-label , prospective , multinational , multicenter study evaluate CSII therapy Accu-Chek Insight Insulin pump routine practice adult subject Type 1 type 2 diabetes . Subjects must intensive insulin therapy least six month i.e . either CSII MDI . All subject receive train preparation , program daily use Accu-Chek Insight Insulin pump . In addition , subject previously MDI may receive train order comfortable use insulin pump . The study conduct 10-12 site Austria , France United Kingdom . A total 80-95 subject enrol study .</brief_summary>
	<brief_title>European , Open-label , Prospective , Multinational , Multicenter Study Adult Subjects With Type 1 Type 2 Diabetes Previously MDI CSII Therapy . Subjects Home Setting Considered Routine Practice .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Male female least 18 year old Diagnosed least 12 month Type 1 2 Diabetes require insulin therapy Intensive insulin therapy MDI CSII least 6 month Willing self monitor blood glucose 4 time daily Significantly impaired awareness hypoglycemia Unstable chronic disease diabetes Acute illness inability recognize pump signal alarm determine investigator Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>